Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than once drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of paclitaxel plus estramustine in treating patients who have metastatic prostate cancer that has not responded to hormone therapy.

Timeline

Start

1998-10

Primary completion

—

Completion

—

Drugs

Indications